Clinical Trials

NCT07037433 | RECRUITING | PHASE3

12800 participants

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2025-07-25

Completion:

2028-06-30

Conditions

• Atherosclerotic Cardiovascular Disease
• Overweight
• Obesity

Interventions

• DRUG

No Results Yet

NCT07035119 | NOT_YET_RECRUITING | PHASE1/PHASE2

50 participants

Transcranial Magnetic Stimulation for Chronic Scrotal Content Pain

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2026-09-30

Completion:

2030-04-01

Conditions

• Scrotal Pain

Interventions

• OTHER

No Results Yet

NCT07026331 | RECRUITING | NA

486 participants

Effect of Balloon Angioplasty vs Stenting Following Residual Stenosis After Endovascular Treatment of Intracranial Atherosclerotic Acute Ischemic Stroke

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2025-07-03

Completion:

2027-04-01

Conditions

• Acute Ischemic Stroke
• Intracranial Atherosclerosis ICAS

Interventions

• PROCEDURE

No Results Yet

NCT07013487 | RECRUITING | PHASE3

12000 participants

A Study to Evaluate V181 Dengue Vaccine in Healthy Participants 2 to 17 Years of Age (V181-005/MOBILIZE-1)

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2025-06-11

Completion:

2031-10-24

Conditions

• Healthy

Interventions

• BIOLOGICAL

No Results Yet

NCT07009288 | RECRUITING | NA

300 participants

A Study of Time-Restricted Eating in Childhood Cancer Survivors

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2025-05-27

Completion:

2030-05-01

Conditions

• Childhood Cancer Survivors

Interventions

• OTHER

No Results Yet

NCT07006896 | ACTIVE_NOT_RECRUITING | NA

100 participants

Induction of Labor After Cesarean Using Foley Alone vs. Concurrent Foley and Oxytocin

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2025-07-10

Completion:

2026-07-25

Conditions

• Labor Induction
• Cesarean Delivery

Interventions

• DEVICE
• DRUG

No Results Yet

NCT07005154 | RECRUITING | PHASE2

218 participants

A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2025-08-19

Completion:

2032-05-31

Conditions

• Prostate Cancer
• Metastatic Castration-Resistant Prostate Cancer
• Metastatic Hormone Sensitive Prostate Cancer

Interventions

• DRUG

No Results Yet

NCT07000929 | COMPLETED

175 participants

Videonystagmography and Vestibular Migraine

Study Type:

OBSERVATIONAL

Last Updated:

2026-09-03

Start Date:

2023-10-16

Completion:

2025-12-31

Conditions

• Migraine Disorders
• Vertigo

Interventions

• DIAGNOSTIC_TEST

No Results Yet

NCT06999837 | RECRUITING | NA

40 participants

[68Ga]Ga-PSMA PET/CT in Hepatocellular Carcinoma: Impact of Multiparametric Dynamic Whole-body Imaging and Kinetic Modeling.

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2025-09-23

Completion:

2028-09-23

Conditions

• HCC - Hepatocellular Carcinoma

Interventions

• RADIATION

No Results Yet

NCT06990269 | RECRUITING | PHASE2

240 participants

Phase 2 Study of ADX-038 in Participants With Geographic Atrophy

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2025-11-10

Completion:

2030-02-28

Conditions

• Geographic Atrophy Secondary to Age-related Macular Degeneration

Interventions

• DRUG

No Results Yet

NCT06989359 | RECRUITING | PHASE2

45 participants

Phase 2 Study of ADX-038 in Complement-Mediated Kidney Disease

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2025-08-28

Completion:

2028-12-31

Conditions

• IgAN
• C3G
• Complement-mediated Kidney Disease
• IgA Nephropathy (IgAN)
• IC-MPGN

Interventions

• DRUG

No Results Yet

NCT06989112 | RECRUITING | PHASE3

600 participants

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2025-03-27

Completion:

2029-01-19

Conditions

• Endometrial Cancer

Interventions

• DRUG

No Results Yet

NCT06987383 | NOT_YET_RECRUITING | PHASE3

40 participants

Vibegron for ENergy Thinking and Resilience in Aging

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2026-10-31

Completion:

2028-07-31

Conditions

• Obesity

Interventions

• DRUG

No Results Yet

NCT06986967 | RECRUITING | NA

30 participants

Retrograde Versus Antegrade Perfusion in Low-Moderate Hypothermia for Aortic Arch Surgery

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2025-04-18

Completion:

2026-12-31

Conditions

• Brain Function
• Hemiarch Cardiac Procedure

Interventions

• PROCEDURE

No Results Yet

NCT06984185 | RECRUITING

106 participants

Early Detection of Type 1 Diabetes

Study Type:

OBSERVATIONAL

Last Updated:

2026-09-03

Start Date:

2025-11-05

Completion:

2027-11-05

Conditions

• Type 1 Diabetes

Interventions

• DIAGNOSTIC_TEST

No Results Yet

NCT06982521 | RECRUITING | PHASE3

540 participants

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2025-08-26

Completion:

2028-04-30

Conditions

• PIK3CA Mutation
• HER2- Negative Breast Cancer
• Hormone Receptor Positive Tumor
• Breast Cancer
• Metastatic Breast Cancer
• Advanced Breast Cancer

Interventions

• DRUG

No Results Yet

NCT06982131 | RECRUITING | PHASE1

40 participants

A Study Investigating the Safety of RO7795081 and the Effect of RO7795081 on How the Body Processes Pitavastatin and Rosuvastatin in Otherwise Healthy Overweight or Obese Adult Participants

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2025-06-04

Completion:

2026-12-07

Conditions

• Overweight
• Obesity

Interventions

• DRUG

No Results Yet

NCT06979453 | RECRUITING | PHASE3

366 participants

A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2025-12-03

Completion:

2029-10-12

Conditions

• Plaque Psoriasis

Interventions

• DRUG
• OTHER

No Results Yet

NCT06976268 | RECRUITING | PHASE2/PHASE3

550 participants

A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2025-05-28

Completion:

2027-08-31

Conditions

• Parkinson Disease

Interventions

• DRUG

No Results Yet

NCT06975176 | NOT_YET_RECRUITING | NA

155 participants

Combating HIV Stigma in Healthcare Settings: A Standardized Patient Approach

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2026-11-01

Completion:

2028-10-31

Conditions

• Hiv

Interventions

• BEHAVIORAL

No Results Yet

NCT06966700 | RECRUITING | PHASE3

2400 participants

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2025-06-30

Completion:

2033-03-23

Conditions

• Breast Neoplasms
• Triple Negative Breast Neoplasms
• HR Low-Positive/HER2-Negative Breast Neoplasms

Interventions

• BIOLOGICAL
• DRUG

No Results Yet

NCT06966492 | NOT_YET_RECRUITING | PHASE4

20 participants

Investigation of the Interplay Between Local Oral Inflammation, Microbiota and Systemic Immune Responses.

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2026-09-30

Completion:

2027-06-30

Conditions

• Gingival Inflammation

Interventions

• DRUG

No Results Yet

NCT06962839 | RECRUITING | PHASE2

300 participants

A Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Diabetic Macular Edema

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2025-06-05

Completion:

2027-09-01

Conditions

• Macular Edema

Interventions

• DRUG

No Results Yet

NCT06960564 | RECRUITING | NA

50 participants

The Effect of Hyaluronic Acid Injection on TNF-Alpha and IL-1β in Knee Osteoarthritis

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2025-05-12

Completion:

2026-09-02

Conditions

• Knee Osteoarthritis
• Hyaluronic Acid

Interventions

• DEVICE
• OTHER

No Results Yet

NCT06959979 | RECRUITING | EARLY_PHASE1

60 participants

Novel Molecular Targets and Innovative Therapeutic Perspective in Medulloblastoma

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2024-11-25

Completion:

2026-08-31

Conditions

• Medulloblastoma, Childhood

Interventions

• DRUG

No Results Yet

NCT06947499 | ACTIVE_NOT_RECRUITING | PHASE2/PHASE3

1186 participants

A Phase II/III Study to Evaluate the Immunogenicity, Safety and Lot-to-lot Consistency of LBVD, a Fully Liquid Hexavalent Diphtheria-tetanus-whole Cell Pertussis-hepatitis B-poliovirus-Haemophilus Influenzae Type b Conjugate (DTwP-HepB-IPV-Hib) Vaccine, in Healthy Infants as Primary Series

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2025-05-30

Completion:

2028-02-28

Conditions

• Diphtheria
• Tetanus
• Pertussis
• Hepatitis B
• Poliomyelitis
• Haemophilus Influenzae Type b

Interventions

• BIOLOGICAL

No Results Yet

NCT06944067 | RECRUITING

50 participants

Study to Understand the Genetic Risk of Developing an Immune Response After Blood Transfusions Among Individuals With Sickle Cell Disease

Study Type:

OBSERVATIONAL

Last Updated:

2026-09-03

Start Date:

2025-06-24

Completion:

2030-04-10

Conditions

• Sickle Cell Disease

No Results Yet

NCT06936709 | NOT_YET_RECRUITING | PHASE4

75 participants

Perioperative Colchicine for TKA

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2026-12-01

Completion:

2027-01-01

Conditions

• Osteoarthritis of Knee
• Recovery Following Primary Total Knee Arthroplasty
• Perioperative Pain Control

Interventions

• DRUG

No Results Yet

NCT06935370 | RECRUITING | PHASE3

4200 participants

A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2025-05-20

Completion:

2029-02-04

Conditions

• Heart Failure

Interventions

• DRUG

No Results Yet

NCT06930495 | ENROLLING_BY_INVITATION

95 participants

The Effect of Adiposity on Muscle and Microvascular Function in HFpEF

Study Type:

OBSERVATIONAL

Last Updated:

2026-09-03

Start Date:

2024-12-10

Completion:

2028-03-01

Conditions

• Heart Failure With Preserved Ejection Fraction (HFPEF)

Interventions

• DRUG

No Results Yet

NCT06925737 | RECRUITING | PHASE3

1440 participants

A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2025-05-13

Completion:

2028-06-26

Conditions

• Prostate Cancer
• Prostatic Neoplasms

Interventions

• DRUG

No Results Yet

NCT06922617 | RECRUITING | NA

240 participants

STEPS: Substance Use Trial of E-cigarettes or Pharmacotherapy for Smoking

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2025-10-17

Completion:

2028-09-01

Conditions

• Tobacco Use
• Substance Use Disorders

Interventions

• BEHAVIORAL
• DRUG

No Results Yet

NCT06922448 | COMPLETED | PHASE2

21 participants

Study of BLU-808 in Allergic Rhinoconjunctivitis

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2025-04-14

Completion:

2025-09-08

Conditions

• Allergic Rhinoconjunctivitis

Interventions

• DRUG

No Results Yet

NCT06922110 | ENROLLING_BY_INVITATION | PHASE3

460 participants

An Open-Label Study of Azetukalner in Major Depressive Disorder

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2025-03-18

Completion:

2027-01-31

Conditions

• Major Depressive Disorder

Interventions

• DRUG

No Results Yet

NCT06921785 | RECRUITING | PHASE3

1220 participants

Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2025-05-06

Completion:

2030-03-15

Conditions

• Hepatocellular Carcinoma

Interventions

• DRUG

No Results Yet

NCT06919653 | NOT_YET_RECRUITING | NA

60 participants

Promoting Adherence to Chemotherapy Handling Guidelines Among Oncology Nurses

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2026-10-31

Completion:

2027-08-31

Conditions

• Chemotherapy Exposure
• Handling Guidelines
• Oncology Nurse
• Adherence

Interventions

• BEHAVIORAL

No Results Yet

NCT06917911 | RECRUITING | PHASE2

162 participants

Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatment Regimen (Cytarabine and Daunorubicin, "7+3") for Core Binding Factor Acute Myeloid Leukemia (CBF-AML) to Improve Response (A MYELOMATCH Treatment Trial)

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2027-02-02

Completion:

2027-11-25

Conditions

• Core Binding Factor Acute Myeloid Leukemia

Interventions

• PROCEDURE
• DRUG

No Results Yet

NCT06916793 | RECRUITING | PHASE3

288 participants

A Phase 3 Study to Evaluate the Safety and Efficacy of CKD-843 in Male Patients With Androgenetic Alopecia

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2025-04-08

Completion:

2027-09-30

Conditions

• Androgenetic Alopecia

Interventions

• DRUG

No Results Yet

NCT06909825 | ACTIVE_NOT_RECRUITING | PHASE2

85 participants

FPI-2265 (225Ac-PSMA-I&T) and Olaparib for Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2025-02-26

Completion:

2027-05-31

Conditions

• Metastatic Castration-resistant Prostate Cancer

Interventions

• DRUG

No Results Yet

NCT06905834 | NOT_YET_RECRUITING | PHASE2

30 participants

Evaluation of Allogenic Mesenchymal Stem Cell (MSC) Injection Therapy for Refractory Graft-versus-Host Disease (GVHD) Unresponsive to Conventional Treatments

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2026-10-31

Completion:

2027-06-30

Conditions

• Dry Eye Disease (DED)
• Graft-Versus-Host Disease(GVHD)

Interventions

• DRUG

No Results Yet